147 related articles for article (PubMed ID: 26332391)
1. Prognostic Significance of Pretreatment Thrombocytosis in Cervical Cancer Patients Treated With Definitive Radiotherapy.
Kawano M; Mabuchi S; Matsumoto Y; Sasano T; Takahashi R; Kuroda H; Kozasa K; Isohashi F; Ogawa K; Kimura T
Int J Gynecol Cancer; 2015 Nov; 25(9):1656-62. PubMed ID: 26332391
[TBL] [Abstract][Full Text] [Related]
2. The Significance of Pretreatment Thrombocytosis and Its Association With Neutrophilia in Patients With Surgically Treated Endometrial Cancer.
Takahashi R; Mabuchi S; Kuroda H; Kozasa K; Yokoi E; Matsumoto Y; Kimura T
Int J Gynecol Cancer; 2017 Sep; 27(7):1399-1407. PubMed ID: 28604454
[TBL] [Abstract][Full Text] [Related]
3. Preoperative thrombocytosis and poor prognostic factors in endometrial cancer.
Heng S; Benjapibal M
Asian Pac J Cancer Prev; 2014; 15(23):10231-6. PubMed ID: 25556452
[TBL] [Abstract][Full Text] [Related]
4. The significance of tumor-associated neutrophil density in uterine cervical cancer treated with definitive radiotherapy.
Matsumoto Y; Mabuchi S; Kozasa K; Kuroda H; Sasano T; Yokoi E; Komura N; Sawada K; Kimura T
Gynecol Oncol; 2017 Jun; 145(3):469-475. PubMed ID: 28552395
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma.
Pardo L; Valero C; López M; García J; Camacho M; Quer M; León X
Auris Nasus Larynx; 2017 Jun; 44(3):313-318. PubMed ID: 27401121
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of pretreatment plasma fibrinogen and platelet levels in patients with early-stage cervical cancer.
Zhao K; Deng H; Qin Y; Liao W; Liang W
Gynecol Obstet Invest; 2015; 79(1):25-33. PubMed ID: 25278089
[TBL] [Abstract][Full Text] [Related]
7. The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer.
Rodriguez GC; Clarke-Pearson DL; Soper JT; Berchuck A; Synan I; Dodge RK
Obstet Gynecol; 1994 Mar; 83(3):445-8. PubMed ID: 8127540
[TBL] [Abstract][Full Text] [Related]
8. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study.
Gadducci A; Cosio S; Zola P; Tisi G; Ferrero A; Piovano E; Cristofani R; Greco C; Sartori E
Int J Gynecol Cancer; 2010 Nov; 20(8):1399-404. PubMed ID: 21051984
[TBL] [Abstract][Full Text] [Related]
10. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
[TBL] [Abstract][Full Text] [Related]
11. The association of pretreatment thrombocytosis with prognosis and clinicopathological significance in cervical cancer: a systematic review and meta-analysis.
Cheng J; Zeng Z; Ye Q; Zhang Y; Yan R; Liang C; Wang J; Li M; Yi M
Oncotarget; 2017 Apr; 8(15):24327-24336. PubMed ID: 28212582
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: a monoinstitutional study.
Takahashi R; Mabuchi S; Kawano M; Sasano T; Matsumoto Y; Kuroda H; Hisamatsu T; Kozasa K; Sawada K; Hamasaki T; Kimura T
Gynecol Oncol; 2015 Apr; 137(1):112-8. PubMed ID: 25680864
[TBL] [Abstract][Full Text] [Related]
13. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.
Todenhöfer T; Renninger M; Schwentner C; Stenzl A; Gakis G
BJU Int; 2012 Dec; 110(11 Pt B):E533-40. PubMed ID: 22578156
[TBL] [Abstract][Full Text] [Related]
14. Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer.
Scholz HS; Petru E; Gücer F; Haas J; Tamussino K; Winter R
Anticancer Res; 2000; 20(5C):3983-5. PubMed ID: 11268488
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
Huang EY; Hsu HC; Sun LM; Chanchien CC; Lin H; Chen HC; Tseng CW; Ou YC; Chang HY; Fang FM; Huang YJ; Wang CY; Lu HM; Tsai CC; Ma YY; Fu HC; Wang YM; Wang CJ
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1105-13. PubMed ID: 20932670
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer.
Onal C; Guler OC; Yildirim BA
Int J Gynecol Cancer; 2016 Jul; 26(6):1169-75. PubMed ID: 27206286
[TBL] [Abstract][Full Text] [Related]
17. Thrombocytosis in surgically treated stage IB squamous cell cervical carcinoma (A Gynecologic Oncology Group study).
Hernandez E; Heller PB; Whitney C; Diana K; Delgado G
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):328-32. PubMed ID: 7835768
[TBL] [Abstract][Full Text] [Related]
18. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas.
Njølstad TS; Engerud H; Werner HM; Salvesen HB; Trovik J
Gynecol Oncol; 2013 Nov; 131(2):410-5. PubMed ID: 24004646
[TBL] [Abstract][Full Text] [Related]
19. The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study.
Hernandez E; Donohue KA; Anderson LL; Heller PB; Stehman FB
Gynecol Oncol; 2000 Aug; 78(2):137-42. PubMed ID: 10926792
[TBL] [Abstract][Full Text] [Related]
20. Thrombocytosis as a prognostic factor in women with cervical cancer.
Lopes A; Daras V; Cross PA; Robertson G; Beynon G; Monaghan JM
Cancer; 1994 Jul; 74(1):90-2. PubMed ID: 8004588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]